Suppr超能文献

广泛期小细胞肺癌预防性颅脑照射的共同决策:一项探索性研究。

Shared decision-making for prophylactic cranial irradiation in extensive-stage small-cell lung cancer: an exploratory study.

作者信息

Ankolekar Anshu, De Ruysscher Dirk, Reymen Bart, Houben Ruud, Dekker Andre, Roumen Cheryl, Fijten Rianne

机构信息

Department of Radiation Oncology (MAASTRO), GROW School for Oncology, Maastricht University Medical Center+, Maastricht, The Netherlands.

出版信息

Transl Lung Cancer Res. 2021 Jul;10(7):3120-3131. doi: 10.21037/tlcr-21-175.

Abstract

BACKGROUND

Prophylactic cranial irradiation (PCI) offers extensive-stage small-cell lung cancer (ES-SCLC) patients a lower chance of brain metastasis and slightly longer survival but is associated with a short-term decline in quality of life due to side-effects. This tradeoff between survival and quality of life makes PCI suitable for shared decision-making (SDM), where patients and clinicians make treatment decisions together based on clinical evidence and patient preferences. Despite recent clinical practice guidelines recommending SDM for PCI in ES-SCLC, as well as the heavy disease burden, research into SDM for lung cancer has been scarce. This exploratory study presents patients' experiences of the SDM process and decisional conflict for PCI.

METHODS

Radiation oncologists (n=7) trained in SDM applied it in making the PCI decision with ES-SCLC patients (n=25). We measured patients' preferred level of participation (Control Preferences Scale), the level of SDM according to both groups (SDM-Q-9 and SDM-Q-Doc), and patients' decisional conflict [decisional conflict scale (DCS)].

RESULTS

Seventy-nine percent of patients preferred a collaborative role in decision-making, and median SDM scores given by patients and clinicians were 80 (IQR: 75.6-91.1) and 85.2 (IQR: 78.7-88.9) respectively, indicating satisfaction with the process. However, patients experienced considerable decisional conflict. Over 50% lacked clarity about which choice was suitable for them and were unsure what to choose. Sixty-four percent felt they did not know enough about the harms and benefits of PCI, and 60% felt unable to judge the importance of the harms/benefits in their life.

CONCLUSIONS

ES-SCLC patients prefer to be involved in their treatment choice for PCI but a substantial portion experiences decisional conflict. Better information provision and values clarification may support patients in making a choice that reflects their preferences.

摘要

背景

预防性颅脑照射(PCI)可降低广泛期小细胞肺癌(ES-SCLC)患者发生脑转移的几率,并使生存期略有延长,但由于副作用,会导致患者生活质量在短期内下降。生存期与生活质量之间的这种权衡使得PCI适用于共同决策(SDM),即患者和临床医生根据临床证据和患者偏好共同做出治疗决策。尽管最近的临床实践指南推荐对ES-SCLC患者的PCI采用SDM,而且该疾病负担沉重,但针对肺癌SDM的研究却很少。这项探索性研究介绍了患者在PCI的SDM过程中的体验和决策冲突。

方法

7名接受过SDM培训的放射肿瘤学家对25例ES-SCLC患者应用SDM来做出PCI决策。我们测量了患者的偏好参与水平(控制偏好量表)、两组的SDM水平(SDM-Q-9和SDM-Q-Doc)以及患者的决策冲突[决策冲突量表(DCS)]。

结果

79%的患者倾向于在决策中发挥协作作用,患者和临床医生给出的SDM评分中位数分别为80(四分位间距:75.6 - 91.1)和85.2(四分位间距:78.7 - 88.9),表明对该过程感到满意。然而,患者经历了相当大的决策冲突。超过50%的患者不清楚哪种选择适合自己,不确定该选什么。64%的患者觉得自己对PCI的危害和益处了解不足,60%的患者觉得无法判断这些危害/益处在其生活中的重要性。

结论

ES-SCLC患者希望参与PCI治疗选择,但很大一部分患者经历了决策冲突。提供更好的信息和阐明价值观可能有助于患者做出符合其偏好的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b777/8350106/6a936e53b739/tlcr-10-07-3120-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验